TIC Solutions, Inc. (TIC): what the price assumes

In the published model solve dated 2026-Q2, anchored at $8.20, TIC Solutions, Inc. (TIC) is priced for -4.0% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-11.

Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/TIC

Headline

FieldValue
TickerTIC
CompanyTIC Solutions, Inc.
Sector / IndustryConsumer Cyclical / Internet Retail
Current price$8.20/sh
CompositionInspection and Mitigation 72% / Consulting Engineering 20% / Geospatial 9%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basisrevenue-multiple
EV / sales paid1.8x
Steady-state operating margin assumed11.7%
Implied growth-4.0%

The company earns no operating profit yet; the inversion runs on the revenue multiple and an assumed steady-state margin.

Solve inputs: computed at a 7.5% cost of capital with 4% terminal growth over a 5-year stage, holding a 11.7% terminal operating margin (29.4% gross margin x the 40% mature-conversion prior); each 1pp of cost of capital moves the implied revenue growth ~6.6pp.

Reconcile: at the x-ray's 9.3% required return this reads ~7.4%/yr; the models below use their own rates.

How unusual the bet is: n/a

ReferenceValue
implied end-window share0%

Valuation X-Ray

The price is supported by asset-based and growth-DCF value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset0.90x2justifies
Earnings0
Relative0
Growth0.69x3justifies

Families that justify the price: Asset, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 6.7%); the inversion above states its own rate.

Per-Model Detail (n=5)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$8.171.00xyesFCF base $0.0B, growth 25% (input: historical growth), terminal g 4.0%, WACC 6.7%, 7yr projection
DCF Exit MultipleGrowth$11.940.69xyesExit EV/EBITDA: 15.1x / 18.1x / 21.1x (bear / base = today's held flat / bull), 7yr
Relative ValuationRelativenoP/S fallback (negative EPS): Sector P/S 1.5x × TTM revenue — excluded from consensus
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$9.650.85xyesBook value floor: BV/sh $9.65, ROE negative
Two-Stage Excess ReturnAsset$8.690.94xyesBook value with convergence: BV/sh $9.65, ROE converges to ke
Discounted Future Market CapGrowth$11.890.69xyesRev $1.8B, growth 30% (input: historical growth; tapered), Terminal P/S: 0.8x / 1.0x / 1.2x (bear / base = today's held flat / bull, cap 12x)
Peter Lynch Fair ValueRelative$0.00noNegative/zero EPS — earnings-based value floored at $0
Margin TrajectoryGrowthnoMargin ramp: -6% → 12% over 7yr, rev growth 30% (input: historical growth; tapered)
Earnings Power ValueEarningsno
Residual IncomeAssetno
Graham NumberAssetno
EV/EBITDA RelativeRelativenoEBITDA $0.17B × sector EV/EBITDA 14.0x
FCF YieldEarnings$0.01819.50xyesFCF $37.2M / Kₑ 9.3% — zero-growth perpetuity (excluded from median)
SBC-Adj FCF YieldEarnings$0.01819.50xyesSBC-adj FCF $0.01B (FCF $0.04B − SBC $0.03B) capitalized at Kₑ (excluded from median)
Ben Graham FormulaEarningsno
ROIC-Justified P/BAssetno
P/Sales SectorRelativenoRevenue $1.78B × sector P/S 1.5x
PEG Fair ValueRelativeno
Earnings YieldEarningsno
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Economic-Unit Decomposition (Sum Of The Parts)

One or more material disclosed units has unresolved economics. Unknown/general is not evidence of homogeneity: segment SOTP is primary but incomplete, consolidated cash flow may remain only a secondary cross-check when every unit shares an enterprise basis, and one sector multiple or target margin is withheld.

UnitRoleValuation basisRevenueReported profitValue evidenceStatus
Inspection and Mitigationoperatingenterprise$1.1bwithheldunresolved no unit value
Consulting Engineeringoperatingenterprise$300.1mwithheldunresolved no unit value
Geospatialoperatingenterprise$131.3mwithheldunresolved no unit value

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

FieldValue
Net debt$1.2b
Burning cashno

Operating profit is negative or near zero and the company has no demonstrated through-cycle (mid-cycle) operating margin to normalize against, so years-to-repay cannot be computed honestly.

Operating profit is negative or near zero and there is no demonstrated through-cycle (mid-cycle) operating margin to normalize against, so interest coverage cannot be computed honestly.

Bullet Takeaways

Bull Case

Trailing valuation models are measuring a company that no longer exists. The twelve-month numbers blend the old standalone Acuren with a partial year of NV5 Global, acquired August 4, 2025 per the 10-K, plus the merger accounting that comes with bolting a similarly sized engineering and geospatial firm onto an inspection business. What those blended trailing figures cannot see is the run-rate: management guides FY2026 to $2.15 to $2.25 billion of revenue and $330 to $355 million of adjusted EBITDA, and first-quarter revenue of $488.0 million grew 108% year over year with 2.2% organic growth underneath the acquisition math. The integration is running ahead of its own promises, with $17 million of cost synergies already achieved and $15 million expected to land in 2026.

The underlying business is the kind that compounds quietly. The 10-K states it plainly: "We generate significant recurring revenue and repeat business from a diversified base of long-standing clients across a variety of end markets", attributing the durability to the essential, compliance-driven nature of the work. Pipelines, refineries, utilities, and infrastructure owners do not skip mandated inspection and asset-integrity work in a downturn; the spending is regulatory, not discretionary. Layering NV5's geospatial data collection and consulting engineering onto that testing base creates cross-selling surface across more than 12,000 professionals and 250-plus locations, and management expects the Consulting Engineering and Geospatial segments to grow fastest in 2026.

The price is not asking for much of this to work. Every family of valuation methods lands at or above today's $7.53 (July 11, 2026): asset-oriented reads put the price at about 0.8x what they support, peer multiples at 0.6x, and even the cautious growth-crediting methods at 0.7x, with the stock trading below its $9.65 stated book value. What the price implies is similarly modest, an eventual operating margin near 11.7% while allowing revenue to shrink a few percent a year. A buyer here is paying value-stock prices for a business guided to grow, with the demanded margin sitting between what the segments individually deliver and what the synergy plan targets. If the integration simply proceeds on its current schedule, the trailing losses that scare the screens roll off the record quarter by quarter.

Bear Case

The valuation methods all technically support this price, and they disagree instructively about why, because each one is capitalizing a different guess about which company TIC turns out to be. The peer-multiple read is the most generous, but it rests on revenue, not profit, since there is no trailing profit to multiply; the trailing twelve months show a $0.10 billion net loss and a negative operating margin. The asset-based read leans on $9.65 of book value per share, but that book is heavily a creation of merger accounting, and the growth methods credit a margin ramp that exists so far mostly in guidance. Support built on three different hypotheticals is thinner than it looks on a summary line, and the honest read is that the market is paying today for an integration that has three quarters of history.

The distress markers deserve their own paragraph. The composite bankruptcy-risk score sits at 0.96, in the formal distress zone, and the fundamental scorecard is weak on nearly every axis: share count rising, debt higher, margins declining, efficiency falling. Debt runs at 0.76x equity, and the 10-K's own risk language notes that the indebtedness creates "additional cash requirements in order to support the payment of interest on our outstanding indebtedness and increase our vulnerability to adverse changes in general economic and industry conditions". Trailing free cash flow of $37.2 million is a 2.2% yield on the market value, thin coverage for a leveraged integration story, and the first quarter alone produced a $41.5 million net loss.

The merger risk is the classic kind. The 10-K's acquisition risk factors list the potential loss of key employees, contractual relationships, and customers of acquired companies, and this is a people business; rope-access technicians, licensed engineers, and geospatial specialists walk out the door if integration is handled badly. The filing also concedes contract renewals may come on less favorable terms, with a material reduction in revenue and earnings if they slip. The gap between the two profit measures is the bear case in one line: GAAP trailing EBITDA of $0.17 billion versus a guided $330 to $355 million of company-adjusted EBITDA. The distance between those numbers is amortization, integration costs, and adjustments, and if the adjusted figure never converges toward GAAP, the value support every model claims to see was priced off a number the income statement cannot produce.

Valuation

Because the company is not yet earning a normal operating profit, the price reads off sales, and the embedded ask is mild: at about 2x revenue, the price implies the business eventually reaches an operating margin around 11.7% and tolerates revenue drifting down a few percent a year. Today's operating margin is slightly negative, so the entire bet is the turnaround to that steady state, not growth on top of it. That is what makes this a different proposition from most loss-making names: the market is underwriting margin normalization, and nothing else.

The methods line up on the supportive side of $7.53 (July 11, 2026). Asset-oriented approaches read the price at roughly 0.8x what they support, with the stock below its $9.65 book value per share; peer multiples read it at 0.6x; growth-crediting methods at 0.7x. No family finds the price expensive, which for a company with a trailing net loss says the market has already discounted the integration risk heavily. The filing-sourced inputs give the frame its substance: the 10-K describes significant recurring, compliance-driven revenue from long-standing clients, and records the NV5 acquisition closing August 4, 2025, the event that reset the revenue base; management's FY2026 guidance of $2.15 to $2.25 billion in revenue implies the trailing $1.78 billion still understates the combined platform's first full year.

Solvency is where the discount earns its keep. The company is lossmaking at the operating line, debt stands at 0.76x equity, and the composite bankruptcy-risk read is in the distress zone, driven by the goodwill-heavy, freshly levered balance sheet; against that, the current ratio of 3.06 provides near-term liquidity and operating cash flow was positive in three of the last four quarters. The number that decides the story is the spread between GAAP results and the guided $330 to $355 million of adjusted EBITDA: each quarter that reported operating income climbs toward the adjusted figure retires a piece of the turnaround risk, and each quarter it does not keeps this a below-book stock for a reason.

Catalysts

The reporting cadence carries the story. First-quarter results landed May 5-6, 2026 with revenue of $488.0 million, up 108% year over year, adjusted EBITDA of $57.7 million, and a $41.5 million net loss; management guided the second quarter to roughly $570 to $582 million of revenue and $90 to $96 million of adjusted EBITDA, and reaffirmed the full-year 2026 outlook of $2.15 to $2.25 billion in revenue and $330 to $355 million in adjusted EBITDA. That puts the early-August print in the position of proving a steep sequential ramp; hitting the Q2 EBITDA range would nearly double the first quarter's profitability in a single step and would be the strongest evidence yet that the adjusted numbers are becoming real ones.

Synergy execution is the second track. The company reports $17 million of cost synergies from the NV5 combination achieved ahead of schedule, with $15 million of savings expected to be realized in 2026; updates to that figure move the margin-normalization math directly. Management has flagged Consulting Engineering and Geospatial as the segments with the higher growth expectations for the year, so segment-level disclosure in the next 10-Q will show whether the acquired NV5 businesses are pulling their weight. The corporate identity work is done, with the Acuren-to-TIC Solutions rebrand effective October 10, 2025, leaving integration, deleveraging, and the quarter-by-quarter convergence of GAAP results toward guidance as the events that will reprice the stock in either direction.

Peer Cohorts (Per Segment, With Filing Citations)

Inspection and Mitigation (reported)

Consulting Engineering (reported)

Geospatial (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Q1 2026 earnings release, May 2026 · Q1 2026 earnings release and call, May 2026 · Q1 2026 earnings call · company rebrand announcement, October 2025 · Q1 2026 earnings call, May 2026 · company announcement

View the full interactive TIC report on boothcheck